120 related articles for article (PubMed ID: 32975794)
1. Evaluating Opioid-Mediated Adenylyl Cyclase Inhibition in Live Cells Using a BRET-Based Assay.
Manandhar P; Sachdev S; Santiago M
Methods Mol Biol; 2021; 2201():117-125. PubMed ID: 32975794
[TBL] [Abstract][Full Text] [Related]
2. Regulation of adenylyl cyclase, ERK1/2, and CREB by Gz following acute and chronic activation of the delta-opioid receptor.
Tso PH; Yung LY; Wong YH
J Neurochem; 2000 Apr; 74(4):1685-93. PubMed ID: 10737627
[TBL] [Abstract][Full Text] [Related]
3. Expression of alpha-transducin in Chinese hamster ovary cells stably transfected with the human delta-opioid receptor attenuates chronic opioid agonist-induced adenylyl cyclase superactivation.
Rubenzik M; Varga E; Stropova D; Roeske WR; Yamamura HI
Mol Pharmacol; 2001 Nov; 60(5):1076-82. PubMed ID: 11641436
[TBL] [Abstract][Full Text] [Related]
4. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins.
Chan JS; Chiu TT; Wong YH
J Neurochem; 1995 Dec; 65(6):2682-9. PubMed ID: 7595566
[TBL] [Abstract][Full Text] [Related]
5. mu-Opioid receptors and not kappa-opioid receptors are coupled to the adenylate cyclase in the cerebellum.
Polastron J; Boyer MJ; Quertermont Y; Thouvenot JP; Meunier JC; Jauzac P
J Neurochem; 1990 Feb; 54(2):562-70. PubMed ID: 2153754
[TBL] [Abstract][Full Text] [Related]
6. Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment.
Avidor-Reiss T; Bayewitch M; Levy R; Matus-Leibovitch N; Nevo I; Vogel Z
J Biol Chem; 1995 Dec; 270(50):29732-8. PubMed ID: 8530363
[TBL] [Abstract][Full Text] [Related]
7. Differential opioid agonist regulation of the mouse mu opioid receptor.
Blake AD; Bot G; Freeman JC; Reisine T
J Biol Chem; 1997 Jan; 272(2):782-90. PubMed ID: 8995364
[TBL] [Abstract][Full Text] [Related]
8. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
Yoshimura M; Ikeda H; Tabakoff B
Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
[TBL] [Abstract][Full Text] [Related]
9. Mediation of adenylyl cyclase sensitization by PTX-insensitive GalphaoA, Galphai1, Galphai2 or Galphai3.
Clark MJ; Traynor JR
J Neurochem; 2006 Dec; 99(6):1494-504. PubMed ID: 17230639
[TBL] [Abstract][Full Text] [Related]
10. Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties.
Brust TF; Alongkronrusmee D; Soto-Velasquez M; Baldwin TA; Ye Z; Dai M; Dessauer CW; van Rijn RM; Watts VJ
Sci Signal; 2017 Feb; 10(467):. PubMed ID: 28223412
[TBL] [Abstract][Full Text] [Related]
11. Opioid-induced adenylyl cyclase supersensitization in human embryonic kidney 293 cells requires pertussis toxin-sensitive G proteins other than G(i1) and G(i3).
Tso PH; Wong YH
Neurosci Lett; 2001 Feb; 299(1-2):25-8. PubMed ID: 11166929
[TBL] [Abstract][Full Text] [Related]
12. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.
Carter BD; Medzihradsky F
Proc Natl Acad Sci U S A; 1993 May; 90(9):4062-6. PubMed ID: 8097884
[TBL] [Abstract][Full Text] [Related]
13. A conserved arginine in the distal third intracellular loop of the mu-opioid receptor is required for G protein activation.
Wang HL
J Neurochem; 1999 Mar; 72(3):1307-14. PubMed ID: 10037504
[TBL] [Abstract][Full Text] [Related]
14. Altered adenylyl cyclase responsiveness subsequent to point mutations of Asp 128 in the third transmembrane domain of the delta-opioid receptor.
Cavalli A; Babey AM; Loh HH
Neuroscience; 1999; 93(3):1025-31. PubMed ID: 10473267
[TBL] [Abstract][Full Text] [Related]
15. G(z) can mediate the acute actions of mu- and kappa-opioids but is not involved in opioid-induced adenylyl cyclase supersensitization.
Tso PH; Wong YH
J Pharmacol Exp Ther; 2000 Oct; 295(1):168-76. PubMed ID: 10991975
[TBL] [Abstract][Full Text] [Related]
16. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase.
Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG
Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231
[TBL] [Abstract][Full Text] [Related]
17. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
Lawrence DM; Bidlack JM
J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
[TBL] [Abstract][Full Text] [Related]
18. Functional domains of delta- and mu-opioid receptors responsible for adenylyl cyclase inhibition.
Megaritis G; Merkouris M; Georgoussi Z
Recept Channels; 2000; 7(3):199-212. PubMed ID: 11342388
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the role of Gi2 in opioid-induced adenylyl cyclase supersensitization.
Tso PH; Wong YH
Neuroreport; 2000 Sep; 11(14):3213-7. PubMed ID: 11043551
[TBL] [Abstract][Full Text] [Related]
20. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites.
Nijssen PC; Sexton T; Childers SR
J Neurochem; 1992 Dec; 59(6):2251-62. PubMed ID: 1331327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
